Next, we used published data from The Cancer Genome Atlas (TCGA) to analyze breast cancer patient samples and found that miR-200a expression was negatively correlated with that of the ELK3 mRNA in 747 breast cancer patient samples. This evidence concerns the gene ELK3 and breast cancer.